Well-Known Viceroy
CORPORATION INFO
| OUT OF CHARACTER INFORMATION |
| Image Source: | [HERE] |
| Canon Link(s): | [n/a] |
| Primary Source(s): | n/a |
| CORPORATION INFORMATION |
| Corporation Name: | SyntheTek Institute |
| Headquarters: | Shadow Town, Nar Shaddaa |
| Additional Locations: | Little Kessel |
| Isolate-5 Laboratory Daluuj Hidden Laboratory Toprawa | |
| Operations: | Bioengineering |
| Cloning | |
| Cybernetics | |
| Parent Corporation: | n/a |
| Subsidiaries: | n/a |
| n/a | |
| n/a |
The SyntheTek Institute, under the directorship of Professor
Dicotylous Ingar
, operates as both a public-facing biomedical research consortium and a covert engine of biological manipulation.Officially, it markets itself as a cutting-edge think tank specializing in regenerative medicine, agricultural gene stabilization, adaptive prosthetics, and deep-space survival augmentation.
Corporate brochures speak of reshaping the future of life sciences. In practice, SyntheTek runs black-site laboratories dedicated to unlicensed cloning programs, forced evolutionary trials, cybernetic grafting, and experimental organ printing for clients who prefer discretion over legality.
SyntheTek's business model is twofold. Publicly, it secures contracts with planetary governments and megacorporations seeking biotech solutions: enhanced labor clones for hazardous industries, agricultural species resistant to blight, or cybernetic augmentation suites for military veterans. Privately, it accepts restricted commissions through encrypted channels.
Crime syndicates, rogue admirals, aristocrats seeking genetic corrections, and intelligence agencies in need of deniable assets may request bespoke creations. Payment is always front-loaded and often laundered through shell subsidiaries and philanthropic research grants.
The Institute does not maintain ideological loyalty to any government or faction; its only consistent allegiance is to advancement and funding. If a regime falls, SyntheTek archives its data, liquidates exposed assets, and resurfaces under a new banner within weeks.
Once a senior bioengineering lecturer at a prestigious academy,
Dicotylous Ingar
became increasingly frustrated by ethical review boards and bureaucratic stagnation that delayed his more ambitious research. He began by founding a private laboratory funded through venture capital and defense grants, marketing adaptive cybernetics for industrial applications.When early prototypes demonstrated alarming potential for combat enhancement, several silent investors stepped forward with significant funding, no questions asked. He leveraged the influx of capital to acquire smaller biotech firms facing bankruptcy, absorbing their patents and personnel through aggressive buyouts.
Competitors who refused acquisition found their funding mysteriously withdrawn or their research discredited through targeted leaks. Within a decade, SyntheTek had grown from a fringe laboratory into a sector-wide authority on applied bioengineering.
The true consolidation of power came when Ingar orchestrated a controlled data breach exposing select rivals' unethical practices, practices far milder than his own. Regulatory bodies dismantled his competition while SyntheTek, shielded by layers of legal insulation and falsified compliance reports, emerged untouched.
By the time oversight committees began to suspect deeper misconduct, SyntheTek's research was too integrated into military supply chains and corporate infrastructure to remove without destabilizing entire systems.